✉news WorldEU Politics first seen 10 h ago, last 1 h ago, peak #14
European Capital Backs Colombian Biotech Firm to Make 250 Million Vaccines
Original: Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines
European investors are injecting capital into a Colombian biotechnology company with plans to produce 250 million vaccines. The deal signals growing confidence in Colombia's pharmaceutical sector and could expand regional vaccine manufacturing capacity, reducing reliance on imports. Details on the investors, funding amount and timelines have not yet been disclosed.
Why now: News of fresh European investment in Latin American vaccine production is drawing attention amid ongoing interest in strengthening local manufacturing.
ColombiaEuropeColombian biotech firm
Rank over time, top of the chart is #1. 8 snapshots from 10 h ago to 1 h ago.
Evidence
- Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines · ColombiaOne.com
API: https://socialmediatrends-api.osmike.com/v1/trends/38631